Rice Hall James & Associates LLC Raises Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Rice Hall James & Associates LLC increased its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 19.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 535,113 shares of the construction company's stock after buying an additional 88,711 shares during the quarter. Rice Hall James & Associates LLC owned 0.70% of Aspen Aerogels worth $14,817,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. GSA Capital Partners LLP purchased a new position in Aspen Aerogels in the first quarter worth $1,181,000. Oppenheimer & Co. Inc. purchased a new position in shares of Aspen Aerogels during the 1st quarter valued at $388,000. Dakota Wealth Management purchased a new position in shares of Aspen Aerogels during the 3rd quarter valued at $986,000. Comerica Bank purchased a new position in shares of Aspen Aerogels during the 1st quarter valued at $1,992,000. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Aspen Aerogels by 66.7% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company's stock valued at $1,922,000 after buying an additional 32,243 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on ASPN shares. Piper Sandler dropped their price objective on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a report on Tuesday, October 22nd. Roth Mkm reissued a "buy" rating and set a $36.00 price objective on shares of Aspen Aerogels in a report on Wednesday, August 21st. Benchmark restated a "buy" rating and issued a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. Barclays assumed coverage on Aspen Aerogels in a report on Tuesday, August 6th. They issued an "overweight" rating and a $27.00 price target on the stock. Finally, StockNews.com raised Aspen Aerogels to a "sell" rating in a report on Thursday. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels currently has an average rating of "Moderate Buy" and a consensus target price of $29.40.

Aspen Aerogels Trading Up 1.2 %

Shares of ASPN stock traded up $0.21 during trading hours on Friday, reaching $18.05. The company's stock had a trading volume of 1,754,886 shares, compared to its average volume of 1,504,659. The stock has a market capitalization of $1.39 billion, a P/E ratio of -1,803.20 and a beta of 2.16. Aspen Aerogels, Inc. has a one year low of $8.05 and a one year high of $33.15. The firm's fifty day simple moving average is $24.29 and its 200 day simple moving average is $24.53. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The company had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. During the same period in the previous year, the company posted ($0.22) earnings per share. The firm's revenue was up 144.4% on a year-over-year basis. Equities research analysts expect that Aspen Aerogels, Inc. will post 0.14 EPS for the current year.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the business's stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares in the company, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the company's stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company's stock, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.30% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.